Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 2:26 PM View:  | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 36% 14.86K to 20.2K | |
| 14-Jun-24 4:13 PM View: | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | 100% 0 to 20.1K | |
| 11-Jun-24 4:19 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 18% 18.54K to 21.94K | |
| 02-Apr-24 6:13 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 138% 109.0K to 259.0K | |
| 22-Mar-24 4:31 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Exercise | 60,000 | $20.92 | $1,254,980.00 | 324% 18.54K to 78.54K | |
| 22-Mar-24 4:31 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Planned Option Sale | 60,000 | $44.14 | $2,648,150.00 | (76%) 78.54K to 18.54K | |
| 11-Mar-24 12:54 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Mar-24 | Sale | 12,195 | $50.88 | $620,443.00 | (45%) 27.05K to 14.86K | |
| 21-Jun-23 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Jun-23 | Grant | 6,000 | -- | -- | 48% 12.54K to 18.54K | |
| 09-Jun-23 2:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 15% 26.5K to 30.36K | |
| 09-Jun-23 2:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Disposition | 3,300 | $51.82 | $171,006.00 | (11%) 30.36K to 27.05K | |
| 02-Jun-23 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 110% 52.0K to 109.0K | |
| 15-Jul-22 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 13-Jul-22 | Option Exercise | 5,700 | $1.45 | $8,265.00 | 45% 12.54K to 18.24K | |
| 15-Jul-22 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 13-Jul-22 | Option Sale | 5,700 | $20.96 | $119,455.00 | (31%) 18.24K to 12.54K | |
| 28-Jun-22 1:52 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-22 | Grant | 3,300 | -- | -- | 14% 23.2K to 26.5K | |
| 27-Jun-22 4:48 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 23-Jun-22 | Grant | 20,500 | -- | -- | 65% 31.5K to 52.0K | |
| 08-Mar-22 12:25 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 04-Mar-22 | Option Exercise | 7,500 | $40.37 | $302,775.00 | 48% 15.7K to 23.2K | |
| 05-Nov-21 4:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 04-Nov-21 | Market Sale (Planned) | 13,354 | $19.50 | $260,403.00 | (30%) 44.85K to 31.5K | (2%) |
| 03-Nov-21 4:55 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-21 | Option Exercise | 8,954 | $1.91 | $17,102.10 | 71% 12.54K to 21.49K | |
| 03-Nov-21 4:55 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-21 | Market Option Sale | 8,954 | $25.50 | $228,327.00 | (42%) 21.49K to 12.54K | |
| 09-Sep-21 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 08-Sep-21 | Option Exercise | 6,046 | $1.91 | $11,547.90 | 48% 12.54K to 18.58K | |
| 09-Sep-21 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 08-Sep-21 | Market Option Sale | 6,046 | $25.50 | $154,173.00 | (33%) 18.58K to 12.54K | |
| 27-Jul-21 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Jul-21 | Option Exercise | 5,000 | $1.91 | $9,550.00 | 40% 12.54K to 17.54K | |
| 27-Jul-21 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Jul-21 | Market Option Sale | 5,000 | $19.59 | $97,950.00 | (29%) 17.54K to 12.54K | |
| 20-Jul-21 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Jul-21 | Option Exercise | 5,000 | $1.91 | $9,550.00 | 40% 12.54K to 17.54K | |
| 20-Jul-21 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Jul-21 | Market Option Sale | 5,000 | $19.50 | $97,500.00 | (29%) 17.54K to 12.54K | |
| 28-Jun-21 6:24 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-21 | Grant | 2,145 | -- | -- | 16% 13.55K to 15.7K | |
| 09-Jun-21 7:05 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jun-21 | Grant | 11,000 | -- | -- | 32% 33.85K to 44.85K | |
| 08-Jul-20 12:30 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Jul-20 | Option Exercise | 6,181 | $21.00 | $129,801.00 | 46% 13.55K to 19.73K | |
| 08-Jul-20 12:30 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Jul-20 | Market Option Sale (Planned) | 6,181 | $90.00 | $556,290.00 | (31%) 19.73K to 13.55K | (92%) |
| 06-Jul-20 2:21 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jul-20 | Option Exercise | 5,000 | $21.00 | $105,000.00 | 37% 13.55K to 18.55K | |
| 06-Jul-20 2:21 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jul-20 | Market Option Sale (Planned) | 5,000 | $85.00 | $425,000.00 | (27%) 18.55K to 13.55K | (103%) |
| 30-Jun-20 1:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 26-Jun-20 | Grant | 2,550 | -- | -- | 23% 11.0K to 13.55K | |
| 17-Jun-20 5:45 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Jun-20 | Grant | 8,000 | -- | -- | 31% 25.85K to 33.85K | |
| 19-May-20 7:13 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 18-May-20 | Market Sale (Planned) | 1,875 | $75.00 | $140,625.00 | (15%) 12.88K to 11.0K | (130%) |
| 24-Apr-20 1:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Apr-20 | Market Sale (Planned) | 1,875 | $65.00 | $121,875.00 | (13%) 14.75K to 12.88K | (166%) |
| 24-Feb-20 7:32 PM View: | Dermira, Inc. (DERM) | 20-Feb-20 | Disposition | 5,051 | $18.75 | $94,706.20 | (100%) 5.05K to 0 | |
| 26-Dec-19 4:13 PM View: | Dermira, Inc. (DERM) | 24-Dec-19 | Private Sale (Planned) | 3,000 | $15.00 | $45,000.00 | (37%) 8.05K to 5.05K | |
| 18-Dec-19 6:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Dec-19 | Option Exercise | 3,500 | $1.91 | $6,685.00 | 28% 12.54K to 16.04K | |
| 18-Dec-19 6:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Dec-19 | Market Option Sale (Planned) | 3,500 | $22.50 | $78,750.00 | (22%) 16.04K to 12.54K | |
| 13-Dec-19 5:13 PM View: | Dermira, Inc. (DERM) | 12-Dec-19 | Private Sale (Planned) | 3,000 | $12.00 | $36,000.00 | (27%) 11.05K to 8.05K | |
| 16-Sep-19 4:09 PM View: | Dermira, Inc. (DERM) | 12-Sep-19 | Market Sale | 6,000 | $8.77 | $52,636.20 | (35%) 17.05K to 11.05K | (14%) |
| 01-Jul-19 5:00 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-19 | Grant | 4,000 | -- | -- | 18% 21.85K to 25.85K | |
| 14-Jun-19 5:16 PM View: | Dermira, Inc. (DERM) | 12-Jun-19 | Option Exercise | 3,000 | -- | -- | 21% 14.05K to 17.05K | |
| 13-Jun-19 4:44 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 11-Jun-19 | Grant | 3,000 | -- | -- | 26% 11.75K to 14.75K | |
| 08-Feb-19 5:41 PM View: | MacRogenics Inc (MGNX) | 06-Feb-19 | Option Exercise | 6,924 | $20.15 | $139,519.00 | 1385% 0.5K to 7.42K | |
| 08-Feb-19 5:41 PM View: | MacRogenics Inc (MGNX) | 06-Feb-19 | Market Option Sale (Planned) | 6,924 | $29.38 | $203,427.00 | (93%) 7.42K to 0.5K | 17% |
| 19-Oct-18 4:24 PM View: | Dermira, Inc. (DERM) | 19-Oct-18 | Market Sale (Planned) | 4,000 | $13.75 | $55,000.00 | (22%) 18.05K to 14.05K | 43% |
| 20-Jun-18 6:07 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-18 | Grant | 3,000 | -- | -- | 34% 8.75K to 11.75K | |
| 18-Jun-18 4:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 14-Jun-18 | Grant | 1,500 | -- | -- | 7% 20.35K to 21.85K | |
| 14-Jun-18 5:45 PM View: | Dermira, Inc. (DERM) | 13-Jun-18 | Option Exercise | 3,000 | -- | -- | 20% 15.05K to 18.05K |